Lymphomas
276 results
1 - 100
Lymphomas 
Antibody therapies for lymphoma in children- Mediastinal Hodgkin lymphoma - Image
- Interventions for AIDS-associated Hodgkin's lymphoma
- A T-cell lymphoma on the upper lip - Image
- Interferon‐alpha for maintenance of follicular lymphoma
Hep C infection increases risk of non-Hodgkin lymphoma- T-cell lymphoma of the skin (Mycosis fungoides) - Image
- Rituximab as maintenance therapy for patients with follicular lymphoma
- Risk of lymphoma not increased among patients with inflammatory bowel disease
- Chemotherapy plus Rituximab versus chemotherapy alone for B‐cell non‐Hodgkin's lymphoma
- Rituximab as maintenance therapy for patients with follicular lymphoma: Cochrane systematic review
- Breast implant–associated lymphoma incidence highest with textured implants (1 in 871 implants)
- Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma
- Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma
- Interventions for previously untreated patients with AIDS‐associated Non‐Hodgkin´s Lymphoma
- Therapeutic interventions for Burkitt lymphoma in children: Cochrane systematic review
- Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma: Cochrane systematic review
- Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T‐cell lymphoma
- The role of additional radiotherapy for primary central nervous system lymphoma
- The role of high‐dose chemotherapy with autologous stem cell transplantation in adults with mature T‐cell lymphomas
- Nivolumab for adults with Hodgkin's lymphoma (a rapid review using the software RobotReviewer)
- Interventions for treating AIDS‐associated Hodgkin´s lymphoma in treatment‐naive adults
- Anthracycline-containing regimens for treatment of follicular lymphoma in adults: Cochrane systematic review
- Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early‐stage Hodgkin’s lymphoma
- High‐dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non‐Hodgkin Lymphoma (NHL) in adults
- High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults
- Additional plerixafor to granulocyte colony‐stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma
- Role of chemotherapy additional to high-dose methotrexate for primary central nervous system lymphoma (PCNSL): Cochrane systematic review
- High‐dose therapy with autologous stem cell transplantation versus chemotherapy or immuno‐chemotherapy for follicular lymphoma in adults
- High‐dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma
- Positron emission tomography‐adapted therapy for first‐line treatment in adults with Hodgkin lymphoma
- Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer
- High-dose chemotherapy followed by autologous stem cell transplantation (HDT) as first-line therapy in aggressive non-Hodgkin's lymphoma (NHL)
- Chimeric antigen receptor (CAR) T‐cell therapy for people with relapsed or refractory diffuse large B‐cell lymphoma
- Interim PET‐results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta‐analysis of prognostic factor studies
- Comparison of first‐line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma
- Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression‐free survival: individual participant data analysis